Cochrane reviews and systematic reviews of economic evaluations - Amantadine and rimantadine in the prevention and treatment of influenza

Citation
T. Jefferson et al., Cochrane reviews and systematic reviews of economic evaluations - Amantadine and rimantadine in the prevention and treatment of influenza, PHARMACOECO, 16, 1999, pp. 85-89
Citations number
8
Categorie Soggetti
Pharmacology
Journal title
PHARMACOECONOMICS
ISSN journal
11707690 → ACNP
Volume
16
Year of publication
1999
Supplement
1
Pages
85 - 89
Database
ISI
SICI code
1170-7690(1999)16:<85:CRASRO>2.0.ZU;2-H
Abstract
Cochrane reviews provide standardised and regularly updated syntheses of ev idence on the effects of healthcare interventions. We present the rationale for, and some of the results of, a Cochrane review of the effects of amant adine and rimantadine in the prevention and treatment of influenza. The est imates of effect will be incorporated into a decision-making model for tack ling influenza in healthy adults (i.e. soldiers in the British Army). Our s ystematic review of the economics of influenza also provides the internatio nal context within which economic data can be interpreted and assessed as a preliminary to an economic evaluation comparing alternative prevention and treatment strategies. Systematic reviews provide powerful and relatively i nexpensive evidence of effects and tolerability, which is more likely to co nvince decision-makers than evidence from single studies. Additionally, the y can be used to focus clinical trial questions and provide strategic insig ht regarding the state-of-the-art knowledge of effects and economics of com pounds in a specific field.